Daily Signals
Find this valuable? Click here to subscribe and receive these signals straight to your inbox daily.
Daily Investment Brief
February 13, 2026
📢 Press Release Signals
ONMD
7/10
Contracts & Proven Resource Expansions⏱ 6-12 Months
Healthcare | MC: $22.7M | EV: $22.6M | Price: $0.69
$2.79M bookings = 12.3% of $22.6M EV; subscription transition accelerates.
Record 2025 bookings of $2.79M signal accelerating enterprise demand for AI-powered real-world data.
- Materiality: $2.79M bookings represent 12.3% of $22.6M EV, exceeding 10% threshold for Contracts category.
- Strategic: Transition to recurring subscription model enhances long-term revenue visibility in healthcare AI data market.
- Credibility: Multi-year data-delivery agreements with enterprise clients underpin growth; 4.1x YoY bookings increase demonstrates traction.
RDWR
7/10
Significant Capital Allocation⏱ 3-12 Months
Technology | MC: $1.1B | EV: $1.1B | Price: $26.39
$80M buyback = 7.5% of $1.06B EV; capital return underscores confidence.
New $80M share repurchase authorization targets 7.5% of enterprise value.
- Materiality: $80M repurchase represents 7.5% of $1.06B EV, meeting 7-10% bracket for opportunistic capital return.
- Strategic: Buyback follows operational execution in cybersecurity growth markets; reduces dilution risk.
- Credibility: Board-authorized program with 13-month expiry indicates committed capital deployment.
📈 Analyst Catalysts
LVO
10/10
+150% UPSIDEAlliance Global Partners
Communication Services | MC: $55.1M | EV: $43.8M | Price: $4.80
Alliance Global Partners set Price Target to $12.00.
Signal @ $4.80 (0.0% since signal)
Street Consensus: $12.00 (+150.0% Upside).
Read Analyst Note →
CMPS
10/10
+138% UPSIDECompass Point
Healthcare | MC: $561.6M | EV: $410.9M | Price: $5.85
Compass Point set Price Target to $15.00.
Signal @ $6.31 (-7.3% since signal)
Street Consensus: $17.00 (+169.4% Upside).
Read Analyst Note →
HUBS
10/10
+121% UPSIDEBernstein
Technology | MC: $12.1B | EV: $11.5B | Price: $228.95
Bernstein set Price Target to $463.00.
Signal @ $209.28 (+9.4% since signal)
Street Consensus: $383.00 (+83.0% Upside). (Street High)
Read Analyst Note →
💼 Insider Clusters
DNP
7/10
$204K TOTAL
Financial Services | MC: $3.9B | EV: $4.9B | Price: $10.27
Kahrer Mark G.
Director
$204K @ $10.21
Return: +0.6% | Stake: +666.7%
THS
7/10
$8.8M TOTAL
Consumer Defensive | MC: $1.2B | EV: $2.8B | Price: $24.43
Silver Point Capital L.P.
10% Owner
$8.8M @ $24.54
Return: -0.4% | Stake: +7.1%
IMDX
7/10
$3.0M TOTAL
Healthcare | MC: $159.9M | EV: $144.4M | Price: $5.58
Broadwood Partners, L.P.
10% Owner
$3.0M @ $5.75
Return: -3.0% | Stake: +4.6%
🏛️ Congressional Flow
FCN
8/10
Industrials | MC: $5.2B | EV: $5.8B | Price: $160.91
Michael McCaul
REP
$100k-$250k
Trade: 2026-01-21 (~$181.05)
Filed 22 days later
IFF
8/10
2 MEMBERS
Basic Materials | MC: $20.9B | EV: $26.3B | Price: $81.50
Michael McCaul
REP
$50k-$100k
Trade: 2026-01-15 (~$70.83)
Filed 28 days later
Michael McCaul
REP
$100k-$250k
Trade: 2026-01-13 (~$69.61)
Filed 30 days later
BAX
7/10
Healthcare | MC: $9.6B | EV: $17.6B | Price: $18.71
Michael McCaul
REP
$50k-$100k
Trade: 2026-01-13 (~$19.65)
Filed 30 days later
Important Disclosures and Disclaimer
Nature of Report: This report is a proprietary research product of Pelican Alpha ("Pelican"). It is provided for informational and discussion purposes only and is based on Pelican's internal analysis and opinions as of the date stated.
Not Investment Advice: This report is not and should not be construed as investment advice, a recommendation to buy or sell any security, or an offer to provide advisory services. The information contained herein does not consider the specific investment objectives, financial situation, or individual needs of any recipient. Recipients should consult with their own independent financial, tax, legal, and other advisors before making any investment decision.
No Fiduciary Relationship: Pelican is not a registered investment advisor or broker-dealer. No fiduciary or advisory relationship is created by providing this report.
Accuracy and Completeness: The information in this report is derived from sources believed to be reliable, but its accuracy, completeness, and timeliness are not guaranteed. Opinions, forecasts, and estimates are subject to change without notice and reflect Pelican's judgment at the time of preparation. Pelican is under no obligation to update this report.
Forward-Looking Statements: This report may contain forward-looking statements that are inherently subject to risks and uncertainties. Actual results could differ materially from those anticipated. There is no assurance that any projected outcomes, catalysts, or expectations will be achieved.
Investment Risk: Investing in securities involves the risk of loss. Past performance is not indicative of future results. The value of investments can fluctuate, and recipients may lose money. All risks discussed in this report (e.g., execution risk, market headwinds, competition) could negatively impact the investment.
Conflicts of Interest: Pelican Alpha, its principals, analysts, employees, or affiliates may hold positions in the securities discussed in this report and may trade these positions at any time without notice.
No Liability: Pelican Alpha assumes no liability for any direct, indirect, incidental, consequential, or other damages arising out of or in connection with the use of this report or the information contained herein.
Proprietary Material: This report is confidential and proprietary to Pelican Alpha and may not be distributed or reproduced without prior written consent.
By reviewing this report, the recipient acknowledges and agrees to these terms. © 2025 Pelican Alpha. All rights reserved.
© 2026 Pelican Alpha. All rights reserved.
This daily briefing provides technical market data, insider transaction clusters,
and quantitative screening results for Pelican Alpha subscribers.
This text serves to ensure proper deliverability and text-to-image ratios
for automated mail security filters processing financial commentary.